TPCW
IDYA icon

TD Private Client Wealth’s IDEAYA Biosciences IDYA Stock Holding History

TD Private Client Wealth’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4
Closed -$138 – 1704
2025
Q4 		$138 Buy
+4
New +$128 ﹤0.01% 1585

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

TD Private Client Wealth's IDYA Position: Q1 2026 in Review

TD Private Client Wealth sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 4 shares — an estimated $138 sold.

TD Private Client Wealth first reported a position in IDYA in Q4 2025 and held it in 1 quarter. The position peaked at $138 in Q4 2025. 254 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • TD Private Client Wealth reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • TD Private Client Wealth sold 4 IDEAYA Biosciences shares in Q1 2026, an estimated $138.
  • TD Private Client Wealth first reported a position in IDEAYA Biosciences in Q4 2025 and held it in 1 quarter.
  • TD Private Client Wealth's IDEAYA Biosciences position peaked at $138 in Q4 2025.
  • 254 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.